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ABSTRACT
Objective: The objective of this study was to find out the etiology of urinary tract infections (UTIs) in patients attending B.K.L. Walawalkar Hospital, 
Dervan and to determine their antibiotic sensitivity pattern to currently used antimicrobial agents.
Methods: A cross-sectional study was conducted in a rural hospital of Konkan Maharashtra, and urine samples were collected from 
368 clinically - suspected cases of UTIs using the mid-stream “clean catch” method and was tested and cultured using standard procedures. Antimicrobial 
susceptibility test (AST) was performed for the isolated pathogens according to the Clinical and Laboratory Standards Institute guidelines.
Results: Escherichia coli (54.84%) was the most prevalent uropathogen. 76.47% of the isolated E. coli were found to be extended spectrum beta 
lactamase producers. A higher prevalence rate of resistance was seen among E. coli to the commonly prescribed antibiotic agents. 32 (94.11%) of 
34 E. coli isolates recovered had multiple antibiotic resistance (MAR), with 16 isolates (50%) possessing MAR indices of 0.6.
Conclusion: The study indicates the isolated microorganisms in UTI showed very high resistance to the commonly prescribed antimicrobial drugs. 
This suggests the monitoring and rational use of the antimicrobial agents.
Keywords: Mid-stream, Culture, Uropathogen, Resistance, Multiple antibiotic resistance.
INTRODUCTION
Urinary tract infections (UTIs) are some of the most common infections 
that occur in both male and female of all the ages, exceeded in frequency 
only by respiratory and gastrointestinal infections among ambulatory 
patients [1].
About 80-85% of community-acquired UTIs are caused by Escherichia 
coli and 5-10% by the Staphylococcus saprophyticus [2]. UTI cases are 
often treated empirically, and the antimicrobial resistance patterns of 
the urinary pathogens determine this empirical therapy [3]. However, 
uncontrolled antibiotic usage in large proportion has contributed 
to the emergence of microbial resistance to antibiotics. As a result, 
antimicrobial resistance is the more prevalent worldwide among 
urinary pathogens [4-7].
For this reason, having the knowledge of the changes in drug resistance 
patterns in specific geographical locations may help clinicians to choose 
the empirical antimicrobial treatment appropriately. The literature 
on the prevalence of UTI in this part of rural Maharashtra was scarce 
in recent decades; thereby, this study was conducted to find out the 
prevalence of UTI and to determine the antimicrobial susceptibility 
patterns of commonly used antibiotics.
METHODS
The study was performed on UTI cases attending B.K.L. Walawalkar 
Hospital, Dervan from July 2015 to December 2015 after ethical 
clearance from the Institution Review Board. A total of 368 clean 
catch midstream urine samples were collected in a wide mouth sterile 
container from the study subjects who had not taken antimicrobials in 
last 15 days. They were instructed to clean the area around the urethral 
opening with clean water, dry the area, and collect the urine with the 
labia held apart. Only one specimen per patient was accepted, and 
samples were processed within 1 hr of collection.
For culture, the urine sample (1 μl) was inoculated on Blood Agar and 
McConkey Agar plates, using a standard loop of internal diameter 
1.34 mm (semi-quantitative method). The plates were read after 24 hrs 
of aerobic incubation at 37°C. They were further incubated for another 
24 hrs before a negative report was issued. A specimen was considered 
positive for UTI if a single organism was cultured at a concentration 
of ≥105 cfu/ml [8]. No mixed infections were encountered.
The isolates were identified and their antibiotic susceptibility determined 
using the automated method for ID/antimicrobial susceptibility test using 
MicroScan (Siemens) rapid Gram-negative and Gram-positive panels. 
Intermediate isolates were counted as resistant to all the agents tested.
The results obtained were analyzed using descriptive statistics. Multiple 
antibiotic resistance (MAR) index is a tool to analyze health risk and is 
helpful to check the spread of bacterial resistance in a given population 
where there is resistance to more than three antibiotics [9]. It is 
calculated as the number of antibiotics to which test isolate displayed 
resistance divided by a total number of antibiotics to which the test 
organism has been evaluated for sensitivity.
RESULTS
A total of 368 urine samples were analyzed for culture and sensitivity 
during the study period, of which 60 (16.3%) had significant bacteriuria. 
The rate of positive culture was 63.33% for female subjects and 36.67% 
for male subjects.
Analysis of the results (Table 1) indicated that E. coli (54.84%) was the 
most prevalent uropathogen followed by Klebsiella pneumonia (9.68%), 
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Pseudomonas aeruginosa (9.68%), Acinetobacter species (9.68%), 
Citrobacter species, and Proteus mirabilis (6.45% each). 76.47% of the 
isolated E. coli were found to be extended spectrum beta lactamase (ESBL) 
producers. No Gram-positive organisms were isolated in this study.
The susceptibility of isolated bacteria to different antimicrobial agents 
is shown in Table 2. E. coli showed high sensitivity to fosfomycin (100%) 
with good susceptibility to tigecycline (88.24%), imipenem (82.35 %), 
meropenem (82.35%), and nitrofurantoin (82.35%) each. The Klebsiella 
showed moderate sensitivity to tigecycline, meropenem, imipenem, 
and fosfomycin (66.67%) each, while it was poorly susceptible to 
the aminoglycosides, fluoroquinolones and cotrimoxazole (33.3%) 
each. Pseudomonas showed 100% sensitivity to amikacin, gentamicin, 
tobramycin, levofloxacin, ciprofloxacin, meropenem, and piperacillin – 
tazobactam. Acinetobacter species show moderate sensitivity to amikacin, 
gentamicin, tobramycin, ceftazidime, levofloxacin, ciprofloxacin, and 
meropenem (66.67% each). Citrobacter species was 100% sensitive to 
amikacin, imipenem, and meropenem. While Proteus species was poorly 
susceptible to most of the antibiotics, growth of Morganella morganii was 
inhibited by piperacillin – tazobactam (100%) alone.
The percentage frequency of MAR is shown in Table 3. In this study, 
we defined MAR as resistance to at least 3 antimicrobial agents [10]. 
32 (94.11%) of 34 E. coli isolates re-covered had MAR, with 16 isolates 
(50%) possessing MAR indices of 0.6.
DISCUSSION
UTIs refer to the presence of microbial pathogens within the urinary 
tract and it is usually classified by the site of infection, if pathogen 
infects bladder (cystitis), if kidney (pyelonephritis), or if urine 
(bacteriuria). Bacteria that infect urinary tract may ascend toward 
the bladder causing cystitis, causing the peculiar symptoms of UTI 
(i.e., pain, frequency, and urgency). Bacteria may further ascend from 
bladder up to kidneys causing pyelonephritis, which may complicate 
later to irreversible kidney damage, renal failure, and death [11]. 
The etiology and antimicrobial susceptibility of UTI-causing 
bacteria’s have been changing over years. Therefore, the overall, 
selecting empiric treatment for the patients with serious UTIs is 
difficult, necessitating the confirmation of etiologic by culture and 
susceptibility testing [12].
In this study, the isolation rate of bacteria from urine was 16.3% 
which is in line with studies done in Assefa et al. [13] and from Iran 
which had a rate of 13.2% [14]. The females were more susceptible to 
UTI than males, which is also similar to other studies [15-17]. Clinical 
UTIs are more common among females, with up to 60% of women 
having at least 1 episode in their lifetime [18]. The reason behind this 
high prevalence is close proximity of the urethral meatus to the anus, 
shorter urethra, sexual intercourse, incontinence, and bad toilet [19]. 
Considering the fact that most of infecting organisms are commensals 
of perianal and vaginal regions, emphasis on personal hygiene, 
especially in females may be important in reducing the incidence of 
UTI [20].
The results of our study show that among the heterogeneous 
causative organisms of UTI, Enterobacteriaceae are the predominant 
pathogens and E. coli is still the single most common uropathogen. This 
corresponds with the data obtained by other investigators [21-23]. 
Klebsiella pneumoniae, P. aeruginosa, Acinetobacter species, Citrobacter 
species, and P. mirabilis were isolated in small numbers while no 
Gram-positive organisms were isolated in this study. E. coli has the 
ability to colonize the urogenital mucosa with adhesins, pili, fimbriae, 
and P1 blood group phenotype receptor [24]. This probably explains its 
higher isolation from UTI.
Over the last decade, the treatment of choice for UTIs has changed 
owing to the rate of resistance and high level of therapeutic failure [25]. 
This study revealed a higher prevalence rate of resistance among 
E. coli to the commonly prescribed antibiotic agents such as ampicillin, 
amoxicillin – clavulanic acid, trimethoprim/sulfamethoxazole, 
norfloxacin, ciprofloxacin, and levofloxacin. The low susceptibility 
Table 1: Distribution of uropathogens isolated in the study
Microorganisms N (%)
Escherichia coli 34 (54.84)
Klebsiella pneumoniae 6 (9.68)
Pseudomonas aeruginosa 6 (9.68)
Acinetobacter species 6 (6.45)
Citrobacter species 4 (3.23)
Proteus mirabilis 4 (9.68)
Morganella morganii 2 (6.45)
Total 62 (100.00)
Table 2: Sensitivity pattern of the isolated organisms (%)




P. mirabilis (4) M. morganii (2)
Amikacin 64.71 33.33 100.00 66.67 100.00 50.00 0.00
Amoxicillin – Clavulanic 
acid
17.65 33.33 NR NR 50.00 50.00 0.00
Ampicillin 0.00 NR NR NR NR 50.00 0.00
Cefepime 5.88 NR 66.67 33.33 NR 50.00 0.00
Cefotaxime 5.88 33.33 NR 0.00 0.00 50.00 0.00
Cefoxitin 64.71 66.67 NR NR 50.00 50.00 0.00
Ceftazidime 5.88 33.33 66.67 66.67 0.00 50.00 0.00
Cefuroxime 5.88 33.33 NR NR 0.00 50.00 0.00
Ciprofloxacin 11.76 33.33 100.00 66.67 0.00 50.00 0.00
Cotrimoxazole 5.88 33.33 NR NR 0.00 50.00 0.00
Fosfomycin 100.00 66.67 NR NR 50.00 50.00 NR
Gentamicin 11.76 33.33 100.00 66.67 50.00 50.00 0.00
Imipenem 82.35 66.67 33.33 0.00 100.00 50.00 0.00
Levofloxacin 35.29 33.33 100.00 66.67 0.00 50.00 0.00
Meropenem 82.35 66.67 100.00 66.67 100.00 50.00 0.00
Nitrofurantoin 82.35 NR NR NR 50.00 NR NR
Norfloxacin 11.76 33.33 33.33 33.33 0.00 50.00 0.00
Piperacillin – Tazobactam 5.88 33.33 100.00 33.33 50.00 50.00 100.00
Tigecycline 100.00 100.00 NR 100.00 100.00 NR NR
Tobramycin 23.53 33.33 100.00 66.67 0.00 50.00 0.00
NR: Not tested and reported, E. coli: Escherichia coli, K. pneumoniae: Klebsiella pneumoniae, P. aeruginosa: Pseudomonas aeruginosa, P. mirabilis: Proteus mirabilis,  
M. morganii: Morganella morganii
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(i.e., higher resistance) of the isolates to the common and cheap orally 
administered antibiotics is not surprising because these drugs are more 
commonly misused, thereby leading to the development of resistance, 
as previously reported [26]. Increased resistance in quinolones against 
E. coli may reflect the overuse of these drugs for the treatment of 
UTI [27]. Thus reducing the number of prescription for a particular 
antibiotic can lead to a decrease in resistance rates. Another factor could 
be the generalized use of fluoroquinolones in animals feed (especially 
in poultry), and the subsequent transmission of resistant to strains 
from animals to humans [28]. These findings are of great importance 
and imply that these antibiotics cannot be used as empirical therapy for 
UTI, particularly in the study area.
On the other hand, while no resistance was detected to tigecycline 
and fosfomycin, lower resistance was detected to nitrofurantoin, 
imipenem, and meropenem. The low resistance could be because they 
are not easily accessible and relatively expensive in price compared to 
others. Thus, these drugs could be considered as alternative options 
in the empirical treatment of UTIs. Resistance to nitrofurantoin 
among E. coli isolates from UTIs has remained low despite more than 
50 year’s widespread use of the drug. Reason for the lack of emerging 
resistance are not fully understood, but likely include restricting use 
to indication for urinary infection, limited systemic absorption, and 
the need for multiple genetic mutations for the bacteria to develop 
resistance [29].
The value of MAR index 0.2 differentiates the low and high risk. MAR 
index >0.2 implies that the strain of such bacteria originate from an 
environment where several antibiotics are used. The MAR indices of 
E. coli obtained in this study is a possible indication that a very large 
proportion of the bacterial isolates have been exposed to several 
antibiotics. In our study, 94.11% isolates of E. coli were MDR. This is 
quite high when compared to other studies [30]. Multi-resistance is 
usually related to production of ESBL, which in our study is very high as 
compared to other recently published data.
CONCLUSION
UTI is one of the common causes for seeking medical attention in 
the community and effective management of patients relays on the 
identification of the type of organisms that caused the disease and the 
selection of an effective antibiotic agent to the organism in question. 
This study provides valuable data to compare and monitor the status 
of antimicrobial resistance. Thus, fosfomycin and nitrofurantoin were 
found to be the most appropriate oral antibiotics and tigecycline, 
imipenem and meropenem were the most appropriate parenteral 
antibiotics, for the empirical therapy of UTIs.
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